Sign In

Robert Estey

CEO at Per Os Biosciences

Robert Estey is the founder and Chief Executive Officer (CEO) of Per Os Biosciences LLC, a company that specializes in manufacturing functional gum, chewable tablets, lozenges, mints, and candy.1

Professional Background

Estey has extensive experience in leading companies through successful turnarounds and start-ups.1 Throughout his career, he has held various financial and operational responsibilities in pharmaceutical and consumer products companies.1 His previous roles include positions at well-known companies such as Pfizer, Praxis Biologics, Lever Bros., and Pennwalt.1

Education and Qualifications

Robert Estey holds a BA degree in Economics from Colgate University and an MBA in Operations Research from the Rochester Institute of Technology.1 He is also a Certified Management Accountant (CMA).1

Current Role

As the CEO of Per Os Biosciences, Estey leads a company that focuses on "Manufacturing Health in a Tasty, Efficient Delivery System".1 The company is known for its innovative approach to creating health-related products in convenient and palatable forms.

Additional Information

  • Estey has approximately 2,000 followers on LinkedIn.2
  • He is based in Hunt Valley, Maryland, United States.2
  • Prior to his current role, Estey was the Founder and CEO of Mastix Medica/Mastix LLC from 2009 to 2018.3

Robert Estey's leadership and experience in the pharmaceutical and consumer products industries have positioned him as a key figure in the functional food and supplement sector.

Highlights

Aug 9 · linkedin

Functional chewing gum as a delivery vehicle for active ingredients is receiving new interest versus the over-saturated number of gummie supplement products. Per Os Biosciences develops hard-to-formulate functional gum products that no other gum manufacturer can approach.

Per Os Biosciences has a multi-patented gum (5 and counting) manufacturing process and is the only company that makes its own powdered gum for compression into a functional gum tablet. This allows Per Os Bio to incorporate both higher doses of active ingredients and more functional ingredients into one gum tablet.

Nicotine is the most well known functional gum. Per Os Bio easily formulated nicotine gum in its innovative gum tablets, but has decided not to compete in this low-margin, commodity-priced market.

Per Os Biosciences focuses on more premium functional gum products like this small sampling of projects/products:

  1. U Penn's anti-viral gum currently in a Phase I/II clinical (https://lnkd.in/eGvgPyYq)
  2. Custom gum for nitric oxide generation and oral microbiome improvement - patented formula composition and gum manufacturing
  3. Soon to launch custom dental gum from Toothpod (https://toothpod.ca/)
  4. Specialized gum formula for NIH-funded clinical study by Biotech company (confidential)

Per Os Biosciences can incorporate almost any functional active into a gum:

  • Energy (Caffeine - anhydrous & natural, paraxanthine, B vitamins, taurine)
  • Nitric oxide generators
  • Oral microbiome balancers
  • Stress/Focus (theanine, 5-HTP, gin+++ many other actives)
  • Dental (hydroxyapatite, peroxide, teeth whiteners)
  • Ayurvedic (ashwagandha, silajit, etc)
  • Immunity (zinc, vitamin c/ascorbic acid, NAC, elderberry)
  • Specialty (electrolytes, amino acids, enzymes, minerals, herbals, saffron)
  • Effervescent/Chelation (sodium bicarbonate, calcium carbonate, citric acid)
  • Cannabinoids (CBD, CBG, Delta-8)

For more information or to develop a custom functional gum as an alternate delivery vehicle versus tablets/capsules, gummies or drinks, contact Robert Estey

Aug 2 · linkedin

An innovative disruptive technology is hitting the nitric oxide market using targeted specialized delivery methods that are more efficient in generating nitric oxide.

Currently, there are two recognized pathways for nitric oxide production:

  1. L-Arginine Pathway: This pathway is efficient in younger individuals but declines with age.
  2. Nitrate Reduction Pathway: Dietary nitrates are converted to nitrites by the oral microbiome and further reduced to nitric oxide in the stomach. This pathway becomes more critical as we age.

Main deficiencies driving inefficient NO conversion:

  • Use of mouthwash (and acid reflux pills) inactivates the oral microbiome
  • Only ~25% of dietary nitrates are delivered through saliva
  • Slow conversion - requires digestion of nitrates and delivery through saliva 45-60 minutes later

💡 New NO Pathway - Prebiotic nitrates and Vitamin C delivered directly into the oral cavity via functional chewing gum or lozenges

Main benefits versus traditional NO pathways

  • immediately creates a favorable oral microbiome ( ⬆ NO converting bacteria) and ( ⬇ pathogenic bacteria).
  • Immediate, efficient generation of nitric oxide - Not waiting for digestion
  • Only product that both creates a favorable microbiome AND generates nitric oxide
  • Patented composition and patented delivery mechanisms (gum/lozenges)
  • Published science (attached) and clinical study underway #nitricoxide

Related Questions

What are Robert Estey's key achievements at Per Os Biosciences?
How did Robert Estey's career evolve before joining Per Os Biosciences?
What are the main products of Per Os Biosciences under Robert Estey's leadership?
What challenges has Robert Estey faced as CEO of Per Os Biosciences?
How has Robert Estey's background in economics and operations research influenced his leadership style?
Robert Estey
Robert Estey, photo 1
Robert Estey, photo 2
Add to my network

Location

Hunt Valley, Maryland, United States